HGH Fragment 176-191
Human Growth Hormone Fragment 176-191
A modified fragment of the C-terminal region of HGH that provides fat-burning benefits without affecting blood sugar or tissue growth. Designed to isolate the lipolytic effects of HGH.
Typical Cost
$50-100/vial (5mg)
Status
Research
Peptide Profile
HGH Fragment 176-191
Mechanism of Action
Mimics the natural way HGH regulates fat metabolism without the adverse effects on blood sugar or growth. Stimulates lipolysis and inhibits lipogenesis through beta-3-adrenergic receptor stimulation.
Common Dosages
subcutaneous
250-500mcg
Daily or 2x daily · 4-8 weeks
Benefits
Targeted fat loss
No blood sugar effects
No IGF-1 elevation
No organ growth
Improved metabolism
Side Effects
Injection site reactions
Limited human data
Banned in sports
Cancer concerns theoretical
Key Research
HGH fragment lipolysis
Demonstrated lipolytic effects without growth-promoting activity in research
Beta-3 receptor mechanism
Fat loss occurs through beta-3-adrenergic receptor pathway
Regulatory Status
Research chemical only. Not FDA-approved. Banned by WADA and most sports organizations.
Contraindications
- ⚠Pregnancy/breastfeeding
- ⚠Active cancer
- ⚠Athletes subject to testing
GLP-1 users achieve superior fat loss through GLP-1 medications. SeraVia Energy+ Boost supports metabolic function safely.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.